ALPS ETF TR - MED BREAKTHGH (SBIO)

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / MED BREAKTHGH
Total 13F shares
1,618,337
Share change
+66,434
Total reported value
$67,537,782
Put/Call ratio
0%
Price per share
$42.24
Number of holders
62
Value change
+$2,754,720
Number of buys
14
Number of sells
28

Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q4 2021

As of 31 Dec 2021, ALPS ETF TR - MED BREAKTHGH (SBIO) was held by 62 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,618,337 shares. The largest 10 holders included MORGAN STANLEY, UBS Group AG, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, Phoenix Holdings Ltd., Matisse Capital, NTV Asset Management LLC, LPL Financial LLC, ROYAL BANK OF CANADA, and COMMONWEALTH EQUITY SERVICES, LLC. This page lists 62 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.